Quintrio
Home

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

IB Acquisition Corp. Common Stock

IBAC

IB Acquisition Corp is a blank check company.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $10.87 – $10.94
Volume 9
Market cap $53M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for IBAC.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for IBAC.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

GNQ Insilico Inc. to go Public Through Business Combination With IB Acquisition Corp. (NASDAQ: IBAC)

GNQ Insilico Inc., an AI and quantum computing-focused drug discovery company, announced a definitive business combination agreement with IB Acquisition Corp. (Nasdaq: IBAC). The transaction values GNQ at US$500 million and is expected to close in Q3 2026, with the combined company listing on Nasdaq. GNQ will provide approximately US$15 million in proceeds and has secured up to US$2 million in bridge financing.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.